National Health Investors (NYSE:NHI) Issues FY 2024 Earnings Guidance

National Health Investors (NYSE:NHI) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided EPS guidance of 4.430-4.440 for the period, compared to the consensus EPS estimate of 4.500. The company issued revenue guidance of -. National Health Investors also updated its FY24 guidance to $4.43-$4.44 EPS.

National Health Investors Trading Up 2.8 %

NHI stock traded up $2.20 during midday trading on Friday, reaching $81.84. The company’s stock had a trading volume of 93,006 shares, compared to its average volume of 194,321. The business’s 50-day simple moving average is $80.37 and its 200-day simple moving average is $73.21. The stock has a market cap of $3.56 billion, a PE ratio of 27.09, a price-to-earnings-growth ratio of 5.05 and a beta of 1.05. National Health Investors has a 52 week low of $50.12 and a 52 week high of $86.13. The company has a quick ratio of 10.27, a current ratio of 10.27 and a debt-to-equity ratio of 0.91.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). The firm had revenue of $63.32 million for the quarter, compared to the consensus estimate of $67.93 million. National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The company’s revenue for the quarter was up 1.7% compared to the same quarter last year. During the same period in the prior year, the business earned $1.08 earnings per share. As a group, sell-side analysts expect that National Health Investors will post 4.48 EPS for the current year.

National Health Investors Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.90 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.40%. National Health Investors’s dividend payout ratio is 122.45%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the stock. Truist Financial lifted their price target on shares of National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research report on Friday, August 30th. Wells Fargo & Company lowered shares of National Health Investors from an “overweight” rating to an “equal weight” rating and raised their price objective for the stock from $81.00 to $86.00 in a report on Tuesday, October 1st. StockNews.com lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, October 15th. Finally, Bank of America initiated coverage on shares of National Health Investors in a report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price objective on the stock. Four research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $73.29.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.